Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,858.00
Bid: 6,847.00
Ask: 6,850.00
Change: 1.00 (0.01%)
Spread: 3.00 (0.04%)
Open: 6,800.00
High: 6,921.00
Low: 6,779.00
Yest. Close: 6,857.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

UK BROKER RATINGS: UBS Raises Randgold Resources To Buy From Neutral

13 Oct 14 08:34

UK MORNING BRIEFING: London Shares Slide At Open On Eurozone Worries

13 Oct 14 07:25

Scientists find lung cancer can lie hidden for 20 years

* Disease evolves over many years along multiple pathways * Diversity helps explain why disease so hard to treat * Research highlights need for earlier detection By Ben Hirschler LONDON, Oct 9 (Reuters) - Lung cancer can lie dormant for more than 20 years before turning de

9 Oct 14 18:00

BUZZ-Innate Pharma: Citi lauds French biotech firm's cancer work

** Shares in French biotechnology company Innate Pharma jump 8 pct as Citi initiates with a "buy" recommendation and 10 euros/share PT. ** French biotech this year: http://link.reuters.com/kag23w ** Innate tipped as a rarity in Europe -- a publicly listed immuno-oncology company with

9 Oct 14 07:43

Woodford sells stake in Reckitt Benckiser

Woodford Investment Management has added to its core holdings in British American Tobacco and G4S in its portfolio but announced it had sold down its stake in Reckitt Benckiser. Speaking about its decision to sell stakes in the multinational consumer goods company, which had been part of the fund fo

7 Oct 14 18:12

London midday: Mining gains offset by falls from airline, healthcare stocks

Poor economic data was weighing on UK stocks on Tuesday, with decent gains in the mining sector offset by falls from airlines and pharmaceuticals. The FTSE 100 was trading 0.6% lower at 6,522 by around midday. Nervousness ahead of the start of third-quarter earnings season in the States was also ca

7 Oct 14 11:36

Tuesday broker round-up UPDATE

African Minerals: Canaccord Genuity lowers target price from 20p to 15p with a hold recommendation. Aggreko: Exane initiates with a target price of 1500p and an underperform rating. Amec: Liberum Capital cuts target price from 1035p to 908p staying with its sell recommendation. Antofagasta: Canacc

7 Oct 14 09:45

UK BROKER RATINGS: Merrill Lynch Cuts Schroders To Underperform

7 Oct 14 08:35

London open: UK stocks drop despite mining gains

Strong gains in the UK mining sector weren't enough to keep London's FTSE 100 from slipping into the red on Tuesday morning. Indices across Europe were tracking a weak finish on Wall Street and a mixed performance on Asian markets overnight. The FTSE 100 was trading 0.6% lower at 6,526 within the o

7 Oct 14 08:27

AstraZeneca heart drug gets preferred status in U.S.

LONDON, Oct 6 (Reuters) - AstraZeneca's blood-thinning drug Brilinta has won preferred status in the United States, where two medical groups have recommended it over the older drug Plavix, also known as clopidogrel. The endorsement comes in an updated guideline from the American Heart Asso

6 Oct 14 11:30

UPDATE 2-Becton Dickinson to buy CareFusion for $12 bln in cash, stock

(Adds details, background) By Deena Beasley Oct 5 (Reuters) - Medical equipment supplier Becton Dickinson & Co has agreed to buy CareFusion Corp , a maker of infusion pumps and other medical devices, for $12.2 billion in cash and stock, marking the latest multibillion-dollar healthcar

6 Oct 14 01:05

UPDATE 1-Becton Dickinson to buy CareFusion for $12 bln in cash, stock

(Adds background, CEO comments) By Deena Beasley Oct 5 (Reuters) - Medical equipment supplier Becton Dickinson & Co has agreed to buy CareFusion Corp , a maker of infusion pumps and other medical devices, for $12.2 billion in cash and stock, marking the latest multibillion-dollar heal

5 Oct 14 21:50

BUZZ-BTG Group: top-ten shareholder adding to stake

** Eighth-largest shareholder Axa Investment Managers adding to stake in biotech firm BTG Group, backing stock to enter FTSE 100. ** Nigel Thomas, manager of the £4.5 bln Axa Framlington UK Select Opportunities fund, increasing the fund's exposure to healthcare through BTG and AstraZeneca.

3 Oct 14 11:59

UPDATE 1-Esperion drug succeeds in lowering LDL cholesterol -study

(Adds share move, analyst forecast) By Bill Berkrot Oct 1 (Reuters) - An experimental cholesterol-fighting drug being developed by Esperion Therapeutics Inc lowered LDL levels significantly more than Merck & Co Inc's Zetia in a midstage clinical trial, Esperion said on Wednesday.

1 Oct 14 20:47

Esperion drug succeeds in lowering LDL cholesterol -study

By Bill Berkrot Oct 1 (Reuters) - A new type of experimental cholesterol fighter being developed by Esperion Therapeutics Inc lowered LDL levels significantly more than Merck & Co Inc's Zetia in a midstage clinical trial, the company said on Wednesday. In the 12-week study involving

1 Oct 14 20:05

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.